Arixtra (fondaparinux natrium) 2.5 mg/0.5 ml. #10

$141.25

Manufactured in: France

Arixtra is prescribed to prevent blood clots in at-risk patients with a usual dosage of 2.5 mg administered as a subcutaneous injection once daily.

SKU: MED3595 Category:

Description

Arixtra (fondaparinux natrium) 2.5 mg/0.5 ml. #10

Arixtra is the brand name for the medication fondaparinux sodium, which is available in the form of 2.5 mg/0.5 ml. solution for injection. This medication is commonly prescribed to prevent blood clots in patients who are at risk due to various medical conditions.

Overview

Arixtra belongs to a class of medications known as anticoagulants or blood thinners. It works by inhibiting the formation of blood clots, therefore reducing the risk of serious conditions such as deep vein thrombosis (DVT) and pulmonary embolism.

Indications

Arixtra is primarily used for the following indications:

  • Prevention of blood clots in patients undergoing surgery
  • Treatment of deep vein thrombosis (DVT)
  • Prevention of pulmonary embolism

Dosage and Administration

The usual dosage of Arixtra is 2.5 mg. administered as a subcutaneous injection once daily. The injection should be given in the abdomen, thigh, or back of the upper arm. It is important to follow the instructions provided by your healthcare provider regarding the dosage and administration of this medication.

Side Effects

Like all medications, Arixtra may cause side effects in some patients. Common side effects include:

  • Bruising or bleeding at the injection site
  • Easy bruising
  • Nausea
  • Headache

If you experience any severe side effects such as signs of bleeding (e.g., blood in urine, black stools), chest pain, or difficulty breathing, seek immediate medical attention.

Precautions

Before using Arixtra, inform your healthcare provider if you have any of the following conditions:

  • History of bleeding disorders
  • Kidney or liver disease
  • Recent surgery or injury
  • Pregnancy or breastfeeding

It is important to follow your healthcare provider’s recommendations and undergo regular monitoring while using Arixtra to ensure its safe and effective use.

Drug Interactions

Arixtra may interact with other medications, including:

  • NSAIDs (non-steroidal anti-inflammatory drugs)
  • Anticoagulants
  • Antiplatelet drugs

Inform your healthcare provider about all the medications you are currently taking to avoid potential drug interactions.

Storage

Store Arixtra at room temperature away from moisture and heat. Keep it out of reach of children and pets. Do not use this medication if the solution is discolored or contains particles.

Conclusion

Arixtra is a medication used to prevent blood clots in patients at risk of thrombotic events. It is important to use this medication as directed by your healthcare provider and to be aware of the potential side effects and precautions associated with its use. If you have any concerns or experience any adverse effects while using Arixtra, contact your healthcare provider immediately for further guidance.